© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
CORRESPONDENCE |
Magnesium sulphate and ischaemic heart disease
* E-mail: subodha_6r@yahoo.co.uk
| The first 10% of the full text of this article appears below. |
EditorWe read with interest Wadhwa and colleagues'1 paper about the use of magnesium sulphate to reduce the shivering threshold. We question whether there is any potential real world use for this proposed therapy of high-dose magnesium in patients with myocardial ischaemia, either peri-infarction, periangioplasty or perioperative coronary bypass graft surgery.
We agree that shivering is undesirable due to the increased oxygen consumption and can increase the risk of myocardial ischaemia. However,
London, UK
E-mail: agdoufas@louisville.edu
Louisville, USA